This is an Advertisement

Articles Tagged with Risperdal

Published on:

Risperdal drug injuryEarlier this month, a jury in Pennsylvania delivered the largest verdict yet against the maker of Risperdal, an antipsychotic medication. A jury awarded a family $70 million as compensation for devastating drug side effects suffered by their son. According to media reports, this is the fifth such lawsuit in Philadelphia, but by far the largest verdict, against Janssen, the manufacturer of Risperdal.

The plaintiff in the lawsuit, a boy who lived in Tennessee, grew large breasts as a result of taking the drug. The condition he suffered from is called gynecomastia, which is a known possible side effect of Risperdal. In marketing the drug and in Janssen’s defense in court, the manufacturer downplayed this side effect – but as this family can tell you, it is an incredibly difficult ordeal for those who develop it.

Risperdal is used in some patients to treat psychiatric disorders. In 2002, the U.S. Food and Drug Administration approved it for use for those who suffered from schizophrenia. In 2003, the FDA approved Risperdal for treatment of manic episodes of bipolar disorder. Since those are limited uses confined to small populations, the company began seeking more ways to market the drug.

Published on:

RisperdalThe Huffington Post is in the midst of publishing a 15-part series that details Johnson & Johnson’s push of the anti-psychotic drug Risperdal. The drug was approved for sale in 1994 for patients with psychosis, but was not approved for use in adolescent or elderly patients. Skirting the Food & Drug Administration and the law became the crux of Johnson & Johnson’s aggressive marketing plan, which was designed to make Risperdal the best-selling anti-psychotic drug on the market.

The series is a bombshell. Three chapters of the 15-chapter series have been published by The Huffington Post so far. Every day brings a new chapter – and more tales of how one of the world’s largest pharmaceutical companies pursued sales at all costs. Selling the drug to approved patient groups for FDA-approved uses wasn’t enough for Johnson & Johnson. Drug sales representatives pushed the drug onto doctors who dealt with psychiatric illnesses in children and elderly, and pushed them to prescribed the drug for symptoms such as agitation in the elderly, which is not an approved use.

Continue reading

Published on:

Risperdal

Risperdal

Plaintiffs seeking a judgment against Johnson & Johnson, the makers of the drug Risperdal, saw a big victory this week out of Philadelphia. A jury sided with the family of an autistic boy who grew size 44 DD breasts after taking Risperdal in 2002. The Wall Street Journal, along with many other publications, wrote about the verdict, which was handed down on February 24, 2015.

Growing breasts was one of several risks that Johnson & Johnson knew about but hid from the Food and Drug Administration, lawyers said. The condition is called gynecomastia. Some patients have been forced to undergo surgery to remove the breasts.

Due to the widespread use of this drug, our firm believes there are many patients who have taken Risperdal and may very well have suffered similar problems, or other side effects. ELPO is accepting cases against Johnson & Johnson, the maker of Risperdal, representing children and their families who have been harmed by Risperdal. The drug treats the symptoms of psychiatric disorders. In addition to gynecomastia, there is an increased risk of stroke and diabetes for patients taking Risperdal.

We want to help patients protect their rights, and encourage anyone who has taken Risperdal or who has a family member who has done so to contact us as soon as possible.

Continue reading